# Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

> **NCT06007586** · PHASE3 · COMPLETED · sponsor: **Sichuan Cancer Hospital and Research Institute** · enrollment: 143 (actual)

## Conditions studied

- Gynecological Tumor
- Ovarian Cancer
- Cervical Cancer
- Endometrial Cancer
- Fallopian Tube Cancer

## Interventions

- **DRUG:** Aprepitant Injection

## Key facts

- **NCT ID:** NCT06007586
- **Lead sponsor:** Sichuan Cancer Hospital and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-31
- **Primary completion:** 2025-06-20
- **Final completion:** 2025-07-04
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06007586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06007586, "Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06007586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*